The stock price of Illumina Inc (NASDAQ: ILMN) has plunged by -0.38 when compared to previous closing price of 85.16, but the company has seen a 0.76% gain in its stock price over the last five trading sessions. prnewswire.com reported 2025-03-19 that Creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO, March 19, 2025 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. Insights from the AGD database are being leveraged to accelerate drug target discovery, therapeutic research and clinical development.
Is It Worth Investing in Illumina Inc (NASDAQ: ILMN) Right Now?
The stock has a 36-month beta value of 1.35. Opinions on the stock are mixed, with 7 analysts rating it as a “buy,” 5 as “overweight,” 11 as “hold,” and 0 as “sell.”
The public float for ILMN is 157.53M, and at present, short sellers hold a 4.13% of that float. On March 19, 2025, the average trading volume of ILMN was 2.61M shares.
ILMN’s Market Performance
ILMN stock saw a decrease of 0.76% in the past week, with a monthly decline of -16.07% and a quarterly a decrease of -41.03%. The volatility ratio for the week is 3.01%, and the volatility levels for the last 30 days are 4.80% for Illumina Inc (ILMN). The simple moving average for the last 20 days is -3.53% for ILMN stock, with a simple moving average of -31.98% for the last 200 days.
Analysts’ Opinion of ILMN
Many brokerage firms have already submitted their reports for ILMN stocks, with Citigroup repeating the rating for ILMN by listing it as a “Neutral.” The predicted price for ILMN in the upcoming period, according to Citigroup is $90 based on the research report published on March 04, 2025 of the current year 2025.
HSBC Securities, on the other hand, stated in their research note that they expect to see ILMN reach a price target of $100. The rating they have provided for ILMN stocks is “Hold” according to the report published on February 28th, 2025.
Barclays gave a rating of “Underweight” to ILMN, setting the target price at $100 in the report published on February 10th of the current year.
ILMN Trading at -23.64% from the 50-Day Moving Average
After a stumble in the market that brought ILMN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -45.84% of loss for the given period.
Volatility was left at 4.80%, however, over the last 30 days, the volatility rate increased by 3.01%, as shares sank -17.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -37.66% lower at present.
During the last 5 trading sessions, ILMN rose by +0.70%, which changed the moving average for the period of 200-days by -16.09% in comparison to the 20-day moving average, which settled at $87.95. In addition, Illumina Inc saw -36.51% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ILMN starting from ARNOLD FRANCES, who proposed sale 120 shares at the price of $93.48 back on Feb 27 ’25. After this action, ARNOLD FRANCES now owns shares of Illumina Inc, valued at $11,218 using the latest closing price.
JAKOB WEDEL, the Officer of Illumina Inc, proposed sale 460 shares at $100.00 during a trade that took place back on Feb 18 ’25, which means that JAKOB WEDEL is holding shares at $46,000 based on the most recent closing price.
Stock Fundamentals for ILMN
Current profitability levels for the company are sitting at:
- 0.31 for the present operating margin
- 0.65 for the gross margin
The net margin for Illumina Inc stands at -0.28. The total capital return value is set at 0.28. Equity return is now at value -30.11, with -14.89 for asset returns.
Based on Illumina Inc (ILMN), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.33. The debt to equity ratio resting at 0.94. The interest coverage ratio of the stock is 13.55.
Currently, EBITDA for the company is -725.0 million with net debt to EBITDA at -1.95. When we switch over and look at the enterprise to sales, we see a ratio of 3.4. The receivables turnover for the company is 5.95for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.78.
Conclusion
To sum up, Illumina Inc (ILMN) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
